comparemela.com

Latest Breaking News On - Avenue therapeutics daily - Page 1 : comparemela.com

Avenue Therapeutics, Inc (NASDAQ:ATXI) Sees Large Growth in Short Interest

Avenue Therapeutics, Inc. (NASDAQ:ATXI – Get Free Report) was the recipient of a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 1,110,000 shares, an increase of 378.9% from the December 31st total of 231,800 shares. Based on an average daily volume of 5,910,000 shares, […]

Avenue Therapeutics, Inc (NASDAQ:ATXI) Sees Large Growth in Short Interest

Avenue Therapeutics, Inc (NASDAQ:ATXI) Sees Large Growth in Short Interest
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Comparing Avenue Therapeutics (NASDAQ:ATXI) and Geron (NASDAQ:GERN)

Avenue Therapeutics (NASDAQ:ATXI – Get Free Report) and Geron (NASDAQ:GERN – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings. Analyst Recommendations This is a breakdown of current […]

Analyzing Geron (NASDAQ:GERN) & Avenue Therapeutics (NASDAQ:ATXI)

Analyzing Geron (NASDAQ:GERN) & Avenue Therapeutics (NASDAQ:ATXI)
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Short Interest in Avenue Therapeutics, Inc (NASDAQ:ATXI) Increases By 39 0%

Avenue Therapeutics, Inc. (NASDAQ:ATXI – Get Free Report) was the target of a large growth in short interest during the month of October. As of October 31st, there was short interest totalling 513,700 shares, a growth of 39.0% from the October 15th total of 369,700 shares. Based on an average trading volume of 156,200 shares, […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.